Prescription medication · Beta-Blocker (Alpha/Beta)

carvedilol

Also sold as Coreg. Carvedilol treats a few different heart conditions.

Data updated 2026-05-15

130,791
FDA reportsHeavily reported
13
InteractionsSeveral interactions
10
Recall records

What the data shows

carvedilol (Coreg) is a prescription Beta-Blocker (Alpha/Beta), more reported than roughly 9 in 10 tracked drugs (130,791 FDA reports), with 13 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

carvedilol (Coreg) is a prescription Beta-Blocker (Alpha/Beta). Carvedilol treats a few different heart conditions.

Carvedilol is a medicine that lowers blood pressure and helps your heart work better. It belongs to a class of drugs called alpha/beta-blockers.

Drug Pricing (NADAC)

Generic Price

$0.02/unit

Generic Available

Yes (11 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: CARVEDILOL 12.5 MG TABLET

Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: -11.8% vs prior release.

Effective NADAC / unit vs prior NDCs
February 21, 2024 $0.0231/EA - 4
December 18, 2024 $0.0204/EA -11.8% 23
Compare with Another Drug → Full Side Effects Report →

What it does

Carvedilol treats a few different heart conditions.

Common side effects

Dizziness, Tiredness, Low blood pressure

Key warnings

Do not stop taking carvedilol suddenly if you have heart problems.

The sections below are summarized in plain English from carvedilol's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Carvedilol works by blocking the effects of certain natural chemicals in your body, such as adrenaline. This helps to relax blood vessels and slows down your heart rate. As a result, it lowers blood pressure and makes it easier for your heart to pump blood.

Side Effects (from patient reports)

Based on 130,791 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for carvedilol, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for carvedilol each year to the FDA Adverse Event Reporting System (FAERS).

05,00010,00015,000 200320062009201220152018202120242025 6,466

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where carvedilol sits

carvedilol has more FDA adverse-event reports than 90% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is carvedilol; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 130,791 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.

Total Reports

130,791

Reports Mentioning Death

15,919

12.2% of reports — not proof of cause

Hospitalization Reports

53,070

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 57,183 (47%)
Male 65,450 (53%)

Age Distribution

0–17 900
18–44 5,607
45–64 28,089
65–74 26,227
75+ 26,948

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FATIGUE 8,669
2 DYSPNOEA 8,178
3 DIARRHOEA 6,867
4 DIZZINESS 6,776
5 NAUSEA 6,492
7 DEATH 5,632
8 HYPOTENSION 5,601
9 ASTHENIA 5,344
10 CARDIAC FAILURE CONGESTIVE 4,427
11 ACUTE KIDNEY INJURY 4,408
13 PAIN 4,341
14 FALL 4,335
15 HEADACHE 4,197
16 RENAL FAILURE 4,183
17 CHRONIC KIDNEY DISEASE 4,025

Reactions in Death Reports

DEATH 5,616
COMPLETED SUICIDE 1,202
RENAL FAILURE 1,049
CARDIAC FAILURE CONGESTIVE 1,030
DYSPNOEA 869
PNEUMONIA 868
CARDIAC ARREST 855
ACUTE KIDNEY INJURY 799
CARDIAC FAILURE 735
HYPOTENSION 710

Reactions in Hospitalization Reports

DYSPNOEA 4,434
CARDIAC FAILURE CONGESTIVE 3,622
PNEUMONIA 3,344
HYPOTENSION 3,313
FATIGUE 3,000
FALL 2,876
ASTHENIA 2,781
MYOCARDIAL INFARCTION 2,733
NAUSEA 2,666
DIARRHOEA 2,663

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Do not stop taking carvedilol suddenly if you have heart problems. This can make chest pain worse and may cause a heart attack. If you need to stop taking carvedilol, your doctor will slowly lower your dose over 1 to 2 weeks. Carvedilol can also cause your heart rate to slow down too much or lower your blood pressure too much. If your pulse rate drops below 55 beats per minute, talk to your doctor about lowering the dose.

Known Drug Interactions

moderate clonidine

( 7.1 , 7.5 ) Hypotensive agents (e.g., reserpine, MAO inhibitors, clonidine) may increase the risk of hypotension and/or severe bradycardia. Concomitant administration of clonidine with a β-blocker may cause hypotension and bradycardia. When concomitant treatment with a β-blocker and clonidine is to be terminated, the β-blocker should be discontinued first.

Mechanism: Both drugs lower blood pressure and slow down the heart rate. Taking them together can make these effects too strong, causing a dangerously slow heart or very low blood pressure.

( 7.8 ) 7.1 CYP2D6 Inhibitors and Poor Metabolizers Interactions of carvedilol with potent inhibitors of CYP2D6 isoenzyme (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol [see Clinical Pharmacology ( 12.3 )] .

Mechanism: Fluoxetine blocks the enzyme that normally clears carvedilol from your blood. This can lead to higher levels of carvedilol in your body.

( 7.8 ) 7.1 CYP2D6 Inhibitors and Poor Metabolizers Interactions of carvedilol with potent inhibitors of CYP2D6 isoenzyme (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol [see Clinical Pharmacology ( 12.3 )] .

Mechanism: Paroxetine prevents your body from breaking down carvedilol as it should. This can cause the level of carvedilol in your blood to increase.

( 7.6 ) Verapamil- or diltiazem-type calcium channel blockers may affect ECG and/or blood pressure. 7.7 Calcium Channel Blockers Conduction disturbance (rarely with hemodynamic compromise) has been observed when carvedilol tablet is coadministered with diltiazem. As with other β-blocker, if carvedilol tablet is administered with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.

Mechanism: Both drugs slow down the heart's electrical signals and lower blood pressure. This can cause the heart to beat too slowly or change its rhythm.

The concomitant administration of amiodarone or other CYP2C9 inhibitors such as fluconazole with carvedilol may enhance the β-blocking activity, resulting in further slowing of the heart rate or cardiac conduction.

Mechanism: Fluconazole prevents the body from breaking down carvedilol properly. This leads to higher levels of the drug in your system, which can slow your heart rate too much.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I drink alcohol while taking carvedilol?
Talk to your doctor about drinking alcohol while taking carvedilol, as it may lower your blood pressure further.
What should I do if I feel dizzy after taking carvedilol?
Lie down when you feel dizzy, especially after taking a dose. Avoid driving or operating machinery until you know how carvedilol affects you.
Can carvedilol affect my blood sugar?
Yes, carvedilol can affect your blood sugar levels. If you have diabetes, monitor your blood sugar closely and talk to your doctor about any changes.
How long does it take for carvedilol to start working?
Carvedilol starts working right away to lower blood pressure, but it may take several weeks to feel the full effects, especially for heart failure.
Can I take carvedilol with other medications?
Tell your doctor about all the medications you take, including over-the-counter drugs and supplements, as some medications can interact with carvedilol.
What if I have asthma?
You should not take carvedilol if you have asthma or related breathing problems.
Does carvedilol cause weight gain?
Weight gain is a possible side effect of carvedilol.
Can carvedilol cause depression?
Although rare, carvedilol may cause depression in some people. Tell your doctor if you experience changes in mood.
Is it safe to exercise while taking carvedilol?
Talk to your doctor before starting any new exercise program while taking carvedilol.
What are the symptoms of low blood pressure?
Symptoms of low blood pressure include dizziness, lightheadedness, fainting, and blurred vision.
What are the common side effects of carvedilol?
The registry lists Dizziness, Tiredness, Low blood pressure, Diarrhea, High blood sugar among the most-reported FAERS reaction terms for carvedilol. The compiled record contains 130,791 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does carvedilol interact with other medications?
The registry has 13 documented interaction rows for carvedilol. Notable source-record pairings include clonidine, fluoxetine, paroxetine. These rows are not a complete medication review.
What drug class is carvedilol?
carvedilol belongs to the Beta-Blocker (Alpha/Beta) drug class. It requires a prescription (Rx). Carvedilol treats a few different heart conditions.
What pregnancy or breastfeeding source fields are listed for carvedilol?
The FDA label for carvedilol contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has carvedilol been recalled?
There are 10 recalls associated with carvedilol products. CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level. Check the recalls section below for full details and affected products.

Active Recalls

Class II August 7, 2025

CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

Glenmark Pharmaceuticals Inc., USA

Class II August 6, 2025

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Glenmark Pharmaceuticals Inc., USA

Class II August 6, 2025

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Glenmark Pharmaceuticals Inc., USA

Class II March 13, 2025

CGMP Deviations

Glenmark Pharmaceuticals Inc., USA

Class II February 28, 2025

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Glenmark Pharmaceuticals Inc., USA

Class II February 28, 2025

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Glenmark Pharmaceuticals Inc., USA

Class II February 28, 2025

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Glenmark Pharmaceuticals Inc., USA

Class II February 28, 2025

CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Glenmark Pharmaceuticals Inc., USA

Class II January 22, 2025

CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Class II January 22, 2025

CGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Other drugs grouped near carvedilol - same-class peers and common alternatives.

Compare carvedilol vs adenosine side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for carvedilol: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on carvedilol

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for carvedilol

The FDA label for carvedilol (sold under brand names such as Coreg) classifies it as a prescription-only medication in the Beta-Blocker (Alpha/Beta) class. Carvedilol treats a few different heart conditions. Official labeling lists 8 commonly reported side effects, including Dizziness, Tiredness, Low blood pressure.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 130,791 voluntary reports. The database also lists 13 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.02.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 10 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: December 2, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page